Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
164.4 SAR | +0.74% | -0.36% | -4.31% |
May. 15 | Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 13 | Dallah Healthcare Posts Higher Q1 Net Profit, Revenue | MT |
Sales 2024 * | 3.3B 880M | Sales 2025 * | 3.55B 947M | Capitalization | 15.94B 4.25B |
---|---|---|---|---|---|
Net income 2024 * | 436M 116M | Net income 2025 * | 514M 137M | EV / Sales 2024 * | 5.35 x |
Net Debt 2024 * | 1.7B 455M | Net Debt 2025 * | 1.68B 447M | EV / Sales 2025 * | 4.96 x |
P/E ratio 2024 * |
37.1
x | P/E ratio 2025 * |
30.8
x | Employees | - |
Yield 2024 * |
1.45% | Yield 2025 * |
1.84% | Free-Float | 41.94% |
1 day | -0.74% | ||
1 week | -1.82% | ||
Current month | -1.82% | ||
1 month | +0.75% | ||
3 months | -10.69% | ||
6 months | -4.71% | ||
Current year | -5.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 08-03-28 | |
Salah Al-Faqih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Talal Al-Maiman
BRD | Director/Board Member | - | - |
Chairman | 67 | 93-12-31 | |
Mohialdeen Kamel
BRD | Director/Board Member | 43 | 16-10-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 112 M€ | +5.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 164.4 | +0.74% | 65 967 |
24-06-05 | 163.2 | -1.57% | 81,429 |
24-06-04 | 165.8 | -0.36% | 78,582 |
24-06-03 | 166.4 | +0.36% | 107,359 |
24-06-02 | 165.8 | +0.48% | 91,676 |
Delayed Quote Saudi Arabian S.E., June 06, 2024 at 03:47 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.70% | 4.25B | |
-23.26% | 15.57B | |
-0.90% | 11.94B | |
+2.49% | 11.59B | |
+3.98% | 10.23B | |
+28.91% | 8.66B | |
-6.48% | 7.44B | |
+7.32% | 6.8B | |
0.00% | 5.96B | |
+6.52% | 4.01B |
- Stock Market
- Equities
- 4004 Stock